http://www.tapanray.in A Tapan Ray Website Sun, 22 Mar 2026 10:59:18 +0000 en-US hourly 1 http://wordpress.org/?v=3.4.2 http://www.tapanray.in/impact-of-the-cost-of-pharma-marketing-failure-on-patients/?utm_source=rss&utm_medium=rss&utm_campaign=impact-of-the-cost-of-pharma-marketing-failure-on-patients http://www.tapanray.in/impact-of-the-cost-of-pharma-marketing-failure-on-patients/#comments Mon, 12 Sep 2022 00:00:09 +0000 Tapan Ray http://www.tapanray.in/?p=10707 Continue reading →]]> http://www.tapanray.in/impact-of-the-cost-of-pharma-marketing-failure-on-patients/feed/ 0 http://www.tapanray.in/what-pays-more-creating-innovative-customer-experience-or-innovative-drugs/?utm_source=rss&utm_medium=rss&utm_campaign=what-pays-more-creating-innovative-customer-experience-or-innovative-drugs http://www.tapanray.in/what-pays-more-creating-innovative-customer-experience-or-innovative-drugs/#comments Mon, 13 Jan 2020 00:00:34 +0000 Tapan Ray http://www.tapanray.in/?p=9851 Continue reading →]]> http://www.tapanray.in/what-pays-more-creating-innovative-customer-experience-or-innovative-drugs/feed/ 0 http://www.tapanray.in/2015-pharma-industry-achieved-some-could-achieve-some-more/?utm_source=rss&utm_medium=rss&utm_campaign=2015-pharma-industry-achieved-some-could-achieve-some-more http://www.tapanray.in/2015-pharma-industry-achieved-some-could-achieve-some-more/#comments Mon, 04 Jan 2016 00:00:18 +0000 Tapan Ray http://www.tapanray.in/?p=7378 Continue reading →]]> http://www.tapanray.in/2015-pharma-industry-achieved-some-could-achieve-some-more/feed/ 0 http://www.tapanray.in/no-more-payment-for-prescriptions-pharma-at-a-crossroads/?utm_source=rss&utm_medium=rss&utm_campaign=no-more-payment-for-prescriptions-pharma-at-a-crossroads http://www.tapanray.in/no-more-payment-for-prescriptions-pharma-at-a-crossroads/#comments Mon, 23 Dec 2013 00:00:09 +0000 Tapan Ray http://www.tapanray.in/?p=4636 Continue reading →]]> http://www.tapanray.in/no-more-payment-for-prescriptions-pharma-at-a-crossroads/feed/ 0 http://www.tapanray.in/grant-of-compulsory-license-for-bayers-nexavar-in-india-raises-more-questions-than-answers/?utm_source=rss&utm_medium=rss&utm_campaign=grant-of-compulsory-license-for-bayers-nexavar-in-india-raises-more-questions-than-answers http://www.tapanray.in/grant-of-compulsory-license-for-bayers-nexavar-in-india-raises-more-questions-than-answers/#comments Mon, 26 Mar 2012 00:00:05 +0000 Tapan Ray http://tapanray.in/index.php/?p=116 Continue reading →]]> http://www.tapanray.in/grant-of-compulsory-license-for-bayers-nexavar-in-india-raises-more-questions-than-answers/feed/ 0 http://www.tapanray.in/maintaining-supply-chain-security-in-pharmaceuticals-the-need-is-now-more-than-ever-before/?utm_source=rss&utm_medium=rss&utm_campaign=maintaining-supply-chain-security-in-pharmaceuticals-the-need-is-now-more-than-ever-before http://www.tapanray.in/maintaining-supply-chain-security-in-pharmaceuticals-the-need-is-now-more-than-ever-before/#comments Mon, 26 Sep 2011 00:00:13 +0000 Tapan Ray http://tapanray.in/index.php/?p=197 Continue reading →]]> http://www.tapanray.in/maintaining-supply-chain-security-in-pharmaceuticals-the-need-is-now-more-than-ever-before/feed/ 0 http://www.tapanray.in/restructure-reposition-and-empower-the-dop-to-deliver-more-to-the-nation-break-the-silos/?utm_source=rss&utm_medium=rss&utm_campaign=restructure-reposition-and-empower-the-dop-to-deliver-more-to-the-nation-break-the-silos http://www.tapanray.in/restructure-reposition-and-empower-the-dop-to-deliver-more-to-the-nation-break-the-silos/#comments Mon, 01 Aug 2011 00:00:44 +0000 Tapan Ray http://tapanray.in/index.php/?p=221 Continue reading →]]> http://www.tapanray.in/restructure-reposition-and-empower-the-dop-to-deliver-more-to-the-nation-break-the-silos/feed/ 0 http://www.tapanray.in/does-china-provide-a-more-robust-ipr-environment-than-india/?utm_source=rss&utm_medium=rss&utm_campaign=does-china-provide-a-more-robust-ipr-environment-than-india http://www.tapanray.in/does-china-provide-a-more-robust-ipr-environment-than-india/#comments Mon, 08 Nov 2010 01:00:09 +0000 Tapan Ray http://tapanray.in/index.php/?p=351 Continue reading →]]> http://www.tapanray.in/does-china-provide-a-more-robust-ipr-environment-than-india/feed/ 0 http://www.tapanray.in/progress-of-the-millennium-development-goals-mdgs-in-india-a-little-to-cheer-more-to-ponder/?utm_source=rss&utm_medium=rss&utm_campaign=progress-of-the-millennium-development-goals-mdgs-in-india-a-little-to-cheer-more-to-ponder http://www.tapanray.in/progress-of-the-millennium-development-goals-mdgs-in-india-a-little-to-cheer-more-to-ponder/#comments Mon, 20 Sep 2010 00:30:05 +0000 Tapan Ray http://tapanray.in/index.php/?p=372 Continue reading →]]> http://www.tapanray.in/progress-of-the-millennium-development-goals-mdgs-in-india-a-little-to-cheer-more-to-ponder/feed/ 0 http://www.tapanray.in/challenges-for-the-pharmaceutical-industry-in-the-new-paradigm-there-are-more-questions-than-answers/?utm_source=rss&utm_medium=rss&utm_campaign=challenges-for-the-pharmaceutical-industry-in-the-new-paradigm-there-are-more-questions-than-answers http://www.tapanray.in/challenges-for-the-pharmaceutical-industry-in-the-new-paradigm-there-are-more-questions-than-answers/#comments Mon, 19 Apr 2010 01:00:54 +0000 Tapan Ray http://tapanray.in/index.php/?p=439 Continue reading →]]> http://www.tapanray.in/challenges-for-the-pharmaceutical-industry-in-the-new-paradigm-there-are-more-questions-than-answers/feed/ 0